Related Experiment Video
Updated: May 17, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
The Hepatitis Aggressiveness Score (HAS): a novel classification system for post-liver transplantation recurrent
Roger K Moreira1, Marcela Salomao, Elizabeth C Verna
1Department of Pathology and Cell Biology, Columbia University College of Physicians and Surgeons, Rochester, MN 55905, USA. moreira.roger@mayo.edu
Insights
A new Hepatitis Aggressiveness Score (HAS) using fibrosing cholestatic hepatitis (FCH) features accurately predicts outcomes in liver transplant recipients with recurrent hepatitis C virus (HCV). This HAS system identifies severe FCH-C cases and stratifies patients by prognosis.
Area of Science:
- Hepatology
- Transplantation Immunology
- Gastroenterology
Background:
- Recurrent hepatitis C virus (HCV) infection post-liver transplantation (LT) is a significant clinical challenge.
- Fibrosing cholestatic hepatitis C (FCH-C) represents a severe form of recurrent HCV.
- Existing grading systems may not fully capture the aggressiveness of recurrent HCV post-LT.
Purpose of the Study:
- To develop and validate a novel histologic grading system for recurrent HCV post-LT based on FCH features.
- To assess the predictive performance of this new system compared to conventional grading methods.
- To stratify patients with recurrent HCV into distinct prognostic categories.
Main Methods:
- Liver biopsies from 170 patients with recurrent HCV post-LT were analyzed.
- Histologic assessment included four FCH features: ductular reaction, cholestasis, hepatocyte ballooning, and periportal sinusoidal fibrosis.
- A Hepatitis Aggressiveness Score (HAS) was derived based on the number of FCH features present.
Main Results:
- The HAS classification significantly predicted fibrosis progression (P<0.001).
- HAS was the strongest predictor of graft loss in multivariable analysis (adjusted hazard ratio=5.5 for HAS 3 vs. HAS 1/2).
- Patients with at least 3 FCH features (HAS 3) showed a distinctly worse prognosis and severe cholestatic disease.
Conclusions:
- A novel grading system based on FCH features (HAS) accurately grades recurrent HCV post-LT.
- The HAS system effectively identifies FCH-C cases and stratifies patients into prognostic groups.
- This approach offers improved prediction of outcomes in liver transplant recipients with recurrent HCV.
Abstract:
Several histopathologic features have been described in cases of fibrosing cholestatic hepatitis C (FCH-C). We investigated whether FCH-associated features can be utilized as the basis of a novel grading system for the entire population of post-liver transplantation (LT) recurrent hepatitis C virus (HCV) infection. Liver biopsies obtained at a median (interquartile range) of 12.3 (10.4-13.8) months post-LT from 170 patients with recurrent HCV were included. Biopsies were assessed for the following FCH features: (1) ductular reaction, (2) cholestasis, (3) hepatocyte ballooning, and (4) periportal sinusoidal fibrosis. A Hepatitis Aggressiveness Score (HAS) was assigned on the basis of the number of FCH features as follows: 0 features=HAS 1; 1 to 2 features=HAS 2; and 3 to 4 features=HAS 3. We analyzed the performance of this novel system in predicting clinicopathologic outcomes compared with conventional grading systems after a median (interquartile range) follow-up of 24 (13-45.5) months. The HAS classification was highly predictive of fibrosis progression (P<0.001) and was the best predictor of graft loss in a multivariable analysis model, which included all conventional hepatitis grading systems (adjusted hazard ratio=5.5, confidence interval 2.9-10.7, P<0.001 for HAS 3 vs. HAS 1 and 2, compared with adjusted hazard ratio=1.0, confidence interval 0.5-1.9, P=0.94 for the presence of moderate to severe necroinflammation by at least 1 conventional grading system). Presence of at least 3 of 4 FCH features (HAS 3 group) characterized a subset of patients with distinctly worse prognosis and severe cholestatic disease (ie, FCH-C). We propose a novel approach to the histologic grading of post-LT recurrent HCV based exclusively on FCH features. This system allows accurate identification of FCH-C cases and stratification of all recurrent HCV patients into distinct prognostic categories.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis I: Introduction
